Ophthalmology Times: October 15, 2021

PRS can modify disease outcomes due to other genes, such as MYOC.

“Real talk” on new devices gives surgeons, patients decision-making insights

Diagnostics, imaging, and therapeutics pave the way for better outcomes.

Ophthalmologist outlines his journey with the procedure as a late adopter.

Retinal and choroidal changes were observed in study.

Procedure transfers intact donor nerve fibers to the cornea.

Targeted antibody testing and therapy offers new options for ophthalmologists

The Academy's annual meeting set for November 12 to 15 in New Orleans.

Demographics show high demand for solutions beyond eyeglasses.

Techniques, technologies minimize complications and guide counseling, care.

Results from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.